What’s the secret to aging well? University of Minnesota Medical School researchers have answered it- on a cellular level.
Aging starts in our cells, and those aging cells can hasten cellular senescence, leading to tissue dysfunction and related health impacts.
New research involving University of Minnesota Medical School faculty Paul D. Robbins and Laura J. Niedernhofer, recently published in Nature Medicine, shows there are types of small molecules called senolytics that can reverse the impact of aged, senescent cells.
“We’ve always thought of aging as a process, not a disease,” said Dr. Robbins, Associate Director of the newly founded Institute on the Biology of Aging and Metabolism (iBAM). “But what if we can influence the impacts of aging at a cellular level to promote healthy aging? That’s what senolytics seeks to achieve.”
The research determined whether introducing senescent cells to human and animal tissue would impact the cellular health of surrounding cells. Surprisingly, the transplant of a relatively small number of senescent cells caused persistent physical dysfunction as well as the spread of cellular senescence in previously healthy cells.
In addition, researchers found that a high fat diet, which causes a type of metabolic stress, or simply being old, enhances the physical dysfunction that comes from senescent cells.
“Previous research has shown that our immune system’s ability to eliminate or deal with senescent cells is based 30 percent on genetics and 70 percent on environment,” said Dr. Robbins, noting that what we eat and how often we exercise can affect senescence or aging of cells.
Conversely, the researchers determined that treatment with senolytic drugs, able to eliminate senescent cells, can reverse physical dysfunction and actually extend lifespan even when used in aged animal models.
“We saw greater activity, more endurance, and greater strength following use of senolytics,” said Dr. Robbins.
The paper notes that the results provide proof-of-concept evidence that improved health and lifespan in animals is possible by targeting senescent cells. The hope is that senolytics will prove effective in alleviating physical dysfunction and resulting loss of independence in older adult humans as well.
“This area of research is promising, not just to address the physical decline that comes with aging, but also to enhance the health of cancer survivors treated with radiation or chemotherapy – two treatments that can induce cell senescence,” said Laura Niedernhofer, Director of iBAM.
The Latest on: Senolytic drugs
via Google News
The Latest on: Senolytic drugs
- Anti-Aging Drugs Could Be On The Market In The Next 5 Yearson September 6, 2019 at 1:30 pm
The upcoming human clinical trials may not be able to stop the aging process, but it is going to interfere with them. Senolytic drugs interfere with zombie senescent cells in the body that accumulate ...
- 'Anti-ageing' drugs could be on the market in five years if clinical trials prove successfulon September 4, 2019 at 5:30 pm
The treatment involves a senolytic drug, a new drug which "interferes with what are called senescent cells, and most of the cells in our bodies turn over after a certain number of growth cycles and ...
- 'Sleeping cells' drive a host of age-related diseases — and new drugs are seeking to rid them from our bodieson August 20, 2019 at 5:22 pm
The science is only just now coming to a place where some senolytic drugs are being tested on humans. The science of senolyticshas also caught the attention of groups trying to achieve dramatic ...
- Global Longevity and Anti-senescence Therapy Marketon June 4, 2019 at 5:00 pm
utm_source=PRN The global longevity and anti-senescence therapy market has been segmented by the following therapies: Senolytic drug therapy, Gene therapy, Immunotherapy and Other therapies which ...
- Global Longevity and Anti-Senescence Therapy Market 2019-2023 - Focus on Senolytic drug therapy, Gene therapy, Immunotherapy and Otherson May 28, 2019 at 5:00 pm
Dublin, May 29, 2019 (GLOBE NEWSWIRE) -- The "Global Longevity and Anti-Senescence Therapy Market" report has been added to ResearchAndMarkets.com's offering. The scope of this report is broad and ...
- Senolytic therapies for healthy longevityon May 16, 2019 at 11:41 am
This has inspired the development of targeted senolytic drugs to eliminate the SNCs that drive age-associated disease in humans. Given that our knowledge of SNCs in vivo is limited, how should ...
- Anti-Aging Drug Reduces Risk Of Age Related Diseaseson April 16, 2019 at 5:39 pm
Not only can an anti-aging drugs make a person look young(er) for their age, they can also help to reduce the risks of having health conditions such as heart disease, cancer, arthritis, diabetes, and ...
- Fascinating picture shows anti-ageing drugs really do workon April 3, 2019 at 6:07 am
This is a stark contrast from the frail, tired-looking mice who did not receive the drugs - and could easily be confused as being twice as old as the treated animals. Researchers found giving the ...
- First-in-human trial of senolytic drugs encouragingon January 7, 2019 at 9:12 am
UT Health San Antonio researchers, collaborating with the Mayo Clinic and the Wake Forest School of Medicine, are the first to publish results on the treatment of a deadly age-related disease in human ...
via Bing News